These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 19845437)

  • 1. Pharmacokinetics and anti-inflammatory pharmacodynamics of prednisolone in cynomolgus monkey.
    Zheng YJ; Hawk M; Yuan H; Hope HR; Baratta M; Zutshi A
    Xenobiotica; 2009 Nov; 39(11):862-70. PubMed ID: 19845437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of prednisolone in children with acute lymphoblastic leukemia.
    Petersen KB; Jusko WJ; Rasmussen M; Schmiegelow K
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):465-73. PubMed ID: 12698270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and delta1-cortienic acid excretion after intravenous administration of prednisolone and loteprednol etabonate in rats.
    Wu WM; Tang Y; Buchwald P; Bodor N
    Pharmazie; 2010 Jun; 65(6):412-6. PubMed ID: 20614688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of prednisolone after intravenous and oral administration.
    Barth J; Damoiseaux M; Möllmann H; Brandis KH; Hochhaus G; Derendorf H
    Int J Clin Pharmacol Ther Toxicol; 1992 Sep; 30(9):317-24. PubMed ID: 1428295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of prednisolone and its local anti-inflammatory steroid-21-oate ester derivatives. In vitro and in vivo comparative study.
    al-Habet SM; Taraporewala IB; Lee HJ
    Drug Metab Dispos; 1990; 18(1):55-60. PubMed ID: 1970778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Problems of equivalency points during therapy with glucocorticoids. A comparison of the clinical pharmacokinetics and pharmacodynamics of prednisolone and methylprednisolone].
    Barth J; Möllmann HW; Wagner T; Hochhaus G; Derendorf H
    Dtsch Med Wochenschr; 1994 Dec; 119(48):1671-6. PubMed ID: 7988369
    [No Abstract]   [Full Text] [Related]  

  • 8. Preclinical pharmacokinetics, interspecies scaling, and tissue distribution of humanized monoclonal anti-IL-13 antibodies with different IL-13 neutralization mechanisms.
    Vugmeyster Y; Szklut P; Tchistiakova L; Abraham W; Kasaian M; Xu X
    Int Immunopharmacol; 2008 Mar; 8(3):477-83. PubMed ID: 18279802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of a humanized monoclonal antibody to factor IX in cynomolgus monkeys.
    Benincosa LJ; Chow FS; Tobia LP; Kwok DC; Davis CB; Jusko WJ
    J Pharmacol Exp Ther; 2000 Feb; 292(2):810-6. PubMed ID: 10640322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics, disposition and lipid-modulating activity of 5-{2-[4-(3,4-difluorophenoxy)-phenyl]-ethylsulfamoyl}-2-methyl-benzoic acid, a potent and subtype-selective peroxisome proliferator-activated receptor alpha agonist in preclinical species and human.
    Frederick KS; Maurer TS; Kalgutkar AS; Royer LJ; Francone OL; Winter SM; Terra SG; Chen D; Gao X
    Xenobiotica; 2009 Oct; 39(10):766-81. PubMed ID: 19622022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB; Dowell JA; Pratt RD
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Animal pharmacokinetics of the tumor necrosis factor receptor-immunoglobulin fusion protein lenercept and their extrapolation to humans.
    Richter WF; Gallati H; Schiller CD
    Drug Metab Dispos; 1999 Jan; 27(1):21-5. PubMed ID: 9884305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of the antimalarial drug, AQ-13, in rats and cynomolgus macaques.
    Ramanathan-Girish S; Catz P; Creek MR; Wu B; Thomas D; Krogstad DJ; De D; Mirsalis JC; Green CE
    Int J Toxicol; 2004; 23(3):179-89. PubMed ID: 15204721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of prednisolone in obese rats.
    Nichols AI; D'Ambrosio R; Pyszczynski NA; Jusko WJ
    J Pharmacol Exp Ther; 1989 Sep; 250(3):963-70. PubMed ID: 2778721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploration of the African green monkey as a preclinical pharmacokinetic model: intravenous pharmacokinetic parameters.
    Ward KW; Coon DJ; Magiera D; Bhadresa S; Nisbett E; Lawrence MS
    Drug Metab Dispos; 2008 Apr; 36(4):715-20. PubMed ID: 18227143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of triclopyr (3,5,6-trichloro-2-pyridinyloxyacetic acid) in the beagle dog and rhesus monkey: perspective on the reduced capacity of dogs to excrete this organic acid relative to the rat, monkey, and human.
    Timchalk C; Nolan RJ
    Toxicol Appl Pharmacol; 1997 Jun; 144(2):268-78. PubMed ID: 9194410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacokinetics of fluocortolone and prednisolone after intravenous and oral administration.
    Täuber U; Haack D; Nieuweboer B; Kloss G; Vecsei P; Wendt H
    Int J Clin Pharmacol Ther Toxicol; 1984 Jan; 22(1):48-55. PubMed ID: 6698661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity and pharmacokinetic properties of ARS-interacting multi-functional protein 1 (AIMP1/p43).
    Han JM; Myung H; Kim S
    Cancer Lett; 2010 Jan; 287(2):157-64. PubMed ID: 19573982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-Carnitine ester of prednisolone: pharmacokinetic and pharmacodynamic evaluation of a type I prodrug.
    Mo J; Lim LY; Zhang ZR
    Int J Pharm; 2014 Nov; 475(1-2):123-9. PubMed ID: 25173636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prednisolone pharmacokinetics and pharmacodynamics in relation to sex and race.
    Magee MH; Blum RA; Lates CD; Jusko WJ
    J Clin Pharmacol; 2001 Nov; 41(11):1180-94. PubMed ID: 11697751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.